Houlihan Lokey Advises Exponent Private Equity

Houlihan Lokey is pleased to announce that Exponent Private Equity LLP (Exponent), a leading European middle-market private equity firm, has agreed to invest in Kingsbridge Healthcare Group (KHG), a leading private healthcare provider in Northern Ireland and the Republic of Ireland. Houlihan Lokey served as the exclusive financing advisor to Exponent on the transaction, which is expected to close during Q3 2024.

Founded in 2004, KHG offers a comprehensive range of medical treatments and services in surgery and diagnostics from its four hospitals and 11 medical centres across Belfast and Ballykelly in Northern Ireland and Sligo in the Republic of Ireland. Over the past two decades, KHG has demonstrated a consistent track record of expanding its capacity as well as clinical capabilities and facilities through acquisition, capital expenditure, and new site development. Over the past three years, KHG has welcomed approximately 150 new medical consultants, bringing the total to more than 400. The company now boasts a workforce of more than 1,100 dedicated professionals.

Established in 2004 and headquartered in London, Exponent is a leading private equity firm that partners with management teams to create market-leading businesses. It focuses on primary investment opportunities and specialises within selected sectors, applying an integrated operational model to deliver revenue-driven profit growth for its portfolio and investors. Now investing from its fourth fund, Exponent has raised more than €3 billion to date. The acquisition of KHG represents Exponent’s first investment in Northern Ireland and their eighth platform investment on the island of Ireland and underscores Exponent’s long-standing commitment to partnering with market-leading, founder-owned businesses.

RELATED: Healthcare, Capital Markets